In a major advance for trauma medicine, researchers at Case Western Reserve University, the University of Pittsburgh and Haima Therapeutics have demonstrated that synthetic platelets can be freeze-dried and remain stable and effective for at least a year at room temperature and at least two months at high temperatures. This unlocks the potential for administering synthetic platelets on a battlefield or on site at a car accident or mass casualty event, which may save more lives.

Oxygen transport, a vital process for sustaining life, is carried out by red blood cells that deliver oxygen to tissues through microscopic capillary networks. Now, researchers from Kyushu University and Institute of Science Tokyo have developed a computational model that simulates this process by combining blood flow, chemical reactions, and oxygen consumption within one system. These simulations reveal that RBCs can adjust the amount of oxygen released based on surrounding oxygen levels, thereby maintaining a stable oxygen concentration across tissues.

A research paper by scientists at Sichuan University presented a water-responsive self-curling adhesive conduit to achieve adaptive wrapping and suture-free repair for peripheral nerve injury.

The research paper, published on Mar 27, 2026 in the journal Cyborg and Bionic Systems.

In a recent study published in Emerging Microbes & Infections, researchers found that seasonal influenza vaccines in routine global use may significantly reduce the risk of death from H5N1 infection. The findings highlight an important implication for pandemic preparedness, suggesting that readily available tools may offer protection while the world races to develop more targeted solutions.

Scientists from Trinity College Dublin and RCSI University of Medicine and Health Sciences have created new “hybrid” immune cells with the potential to help new bone form after a break. The wow-factor here is that the hybrids simultaneously promote blood vessel and bone growth, which is entirely new. 

This discovery could one day help bones regrow more quickly as well as improving outcomes for a huge number of patients – with around 10% of all bone fractures currently failing to heal properly.

A review in Neuroprotection (2026) reconceptualizes Parkinson’s disease as a lifelong neurobiological process shaped by early-life vulnerability, cumulative environmental exposures, and resilience factors. The authors integrate developmental biology, epigenetics, neuroimmune mechanisms, and brain plasticity into a prevention-focused framework. They highlight how early risks and lifelong protective behaviors influence disease trajectory, while emphasizing the need for longitudinal studies, early biomarkers, and targeted interventions to enable prevention rather than late-stage treatment.

A new study uncovers a sophisticated immune evasion strategy used by malaria parasites. Researchers led by Professor Qijun Chen at Shenyang Agricultural University demonstrate that Plasmodium employs its own phosphoinositide 3-kinase to actively prevent the exposure of phosphatidylserine on the surface of infected red blood cells, thereby avoiding recognition and clearance by host macrophages. The findings reveal a previously unknown mechanism of host–pathogen interaction and open a potential avenue for antimalarial drug development.

Shi Yuankai’s team’s review on EGFR-TKIs for NSCLC (2000–2026) came out in the Chinese Medical Journal. Lung cancer leads in global cancer incidence/mortality, with NSCLC as the main subtype and EGFR a key driver. EGFR-TKIs are core for advanced EGFR-mutant NSCLC, with expanded clinical applications and prolonged patient survival. Yet EGFR-TKI resistance is a big challenge; the review summarizes its 2000–2025 development and future directions.